| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Sertraline | Sertraline 2, 3 Dichloro Isomer | VL196016 | View CAS 1198084-29-5 |
| Sertraline | Sertraline 2, 3-Dichloro Imine Impurity | VE006642 | View CAS 340830-05-9 |
| Sertraline | Sertraline EP Impurity A | VL196009 | View CAS 79617-99-5 |
| Sertraline | Sertraline EP Impurity A (Free Base) | VE006651 | View CAS 79836-45-6 |
| Sertraline | Sertraline EP Impurity B | VL196001 | View CAS 52758-05-1 |
| Sertraline | Sertraline EP Impurity C | VL196008 | View CAS 79559-98-1 |
| Sertraline | Sertraline EP Impurity C (Free Base) | VE006652 | View CAS 107538-91-0 |
| Sertraline | Sertraline EP Impurity D | VE006438 | View CAS 871838-58-3 |
| Sertraline | Sertraline EP Impurity D (HCl salt) | VL196007 | View |
| Sertraline | Sertraline EP Impurity E | VL196013 | View CAS 611-71-2 |
| Sertraline | Sertraline EP Impurity F | VL196002 | View CAS 155748-61-1 |
| Sertraline | Sertraline EP Impurity G | VL196003 | View CAS 79645-15-1 |
| Sertraline | Sertraline Mandelic Acid | VL196011 | View |
| Sertraline | Sertraline N-Oxide | VE006284 | View CAS 209473-00-7 |
| Sertraline | Sertraline Related Compound-1 | VL196004 | View |
| Sertraline | Sertraline Related Compound-2 | VL196005 | View |
| Sertraline | Sertraline STHRC-3 | VL196017 | View CAS 79560-20-6 |
| Sertraline | Sertraline Tetralone Racemate | VE008994 | View CAS 79560-19-3 |
| Sertraline | Sertraline for system suitability | VL196015 | View CAS 79559-97-0 |
| Sertraline | 3, 4-deschloro sertraline | VE0011167 | View |
| Sertraline | 3-Deschloro Sertraline (Free Base) | VE0011166 | View CAS 91797-63-6 |
| Sertraline | 3-Deschloro Sertraline (HCl salt) | VL196006 | View CAS 79646-00-7 |
| Sertraline | (1S, 4R)-4-(3, 4-dichlorophenyl)-N-methyl-1, 2, 3, 4-tetrahydronaphthalen-1-amine | VE009922 | View CAS 91797-60-3 |
| Sertraline | (1S, 4S)-2, 3-Dichloro Sertraline Hydrochloride | VE006653 | View |
| Sertraline | (R, R)-Sertraline | VE0011058 | View CAS 79617-98-4 |
Sertraline Related Compound
It is frequently used to treat depression, as well as panic attacks, obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD) (PTSD).
References
- Mahase, Elisabeth. “Sertraline Is Better at Reducing Anxiety than Depressive Symptoms.” BMJ, Sept. 2019, p. l5655, https://doi.org/10.1136/bmj.l5655. Accessed 9 Mar. 2023.
- MacQueen, Glenda, et al. “The Selective Serotonin Reuptake Inhibitor Sertraline: Its Profile and Use in Psychiatric Disorders.” CNS Drug Reviews, vol. 7, no. 1, June 2006, pp. 1–24, https://doi.org/10.1111/j.1527-3458.2001.tb00188.x. Accessed 9 Mar. 2023.
- “Zoloft – SSRI Uses, Interactions & Common Side Effects.” Drugwatch.com, 2022, www.drugwatch.com/ssri/zoloft/#:~:text=Zoloft%20(sertraline%20chloride)%20is%20a,anxiety%20disorder%20and%20panic%20attacks. Accessed 9 Mar. 2023.
FAQ
Can sertraline reduce stress?
Sertraline was more successful in reducing anxiety symptoms, such as anxiousness, irritability, and restlessness, with improvements visible after six weeks, but moderate reductions in depression symptoms, such as poor mood, needed 12 weeks.
Is sertraline a serotonin blocker?
Sertraline is a powerful and selective serotonin uptake inhibitor that is effective in treating mood and anxiety disorders. It has been shown to be effective in treating major depression, dysthymia, OCD, social phobia, panic disorder, and PMDD.
Is sertraline an SSRI or an MAOI?
Sertraline is a selective serotonin reuptake inhibitor (SSRI) that is used to treat depression, PTSD, OCD, social anxiety disorder, and panic attacks.
